Lifeboat Foundation

Much of human invention and innovation has been the result of our discovery and replication of natural phenomena, from birds in flight to whales that dive deep into the ocean. For the first time, researchers have captured at the nanometer level the gliding machinery of the bacterium Mycoplasma mobile. Their findings were published in mBio. It illuminates the origin and operating principle of motility, which could serve as a basis for the next generation of nanoscale devices and pharmaceuticals.

“My lab has been studying the molecular nature of bacteria from the Mycoplasma genus for years,” states Professor Makoto Miyata from the Graduate School of Science, Osaka City University and lead of the research group. “And we have developed a conceptualization of how some of these parasitic bacteria ‘glide’ around their hosts.”

For example, Mycoplasma mobile forms a protrusion at one end giving the bacterium a flask shape. At the tapered end are external appendages that bind to solid surfaces, and in concert with an internal mechanism, cause the bacterium to glide across the surface of its host to find nutrient-rich sites and escape the host’s immune response.

More on thymus regeneration. Unless I understood wrong one patient’s epigenetic clock went from his mid 50’s to early 40’s.

Foresight Biotech & Health Extension Meeting sponsored by 100 Plus Capital.

Continue reading “Greg Fahy, Intervene Immune | Thymus Rejuvenation Progress Update” »

Scientists from Japan’s RIKEN Institute have developed a new ‘dry transfer technique’ which enables the precise positioning of optical-quality carbon nanotubes, without needing a solvent.

The adhesion and colonization or biofilm formation include primary stage in bacterial infections. Major adhesion virulence factors in this step include type I fimbriae (FimH) and pilli structures for attachment to the host cells^7,8. Furthermore, numerous bacteria secrete toxins and extracellular enzymes which play a crucial role in the apoptosis or necrosis of epithelial cells or immunocytes. Various virulence factors of A. baumannii such as adhesins genes like kpsMII (group 2 capsule synthesis) and fimH, tratT (serum resistance associated), fyuA (yersiniabactin receptor) and iutA (aerobactin receptor) have been investigated previously^9,10. An important polysaccharide for biofilm formation is encoded by pgaABCD locus¹¹. Biofilm production is a strategy to escape from harsh conditions and immune responses, hence play as reservoirs for drug-resistant systemic infections. Biofilm-producing A. baumannii has been isolated from several infectious origins such as pneumonia and devise-associated infections. Bacterial within biofilm can resist significantly more against antibiotics compared to planktonic mode of growth¹². Hence, biofilm-mediated infections are in relapse more frequently¹³.

Therefore, there is an urgent need to enhance the effects of antimicrobials against pathogenic bacteria. In recent years, interest has enhanced towards application of nanoparticles as therapeutic regimens^{14,15,16,17,18,19,20,21}. Silver nanoparticles (AgNPs), which have low toxicity in ecosystems and have high rate of surface capacity, can inhibit accumulation of biofilm materials responsible for evasion and protection^22,23,24.

The aim of this study was to isolate A. baumannii from wound infections, determine their resistance and virulence profile, and assess the impact of AgNPs on the bacterial growth, virulence and biofilm-related gene expressions in the isolated strains.

Drug Delivery.

Covid-19

Without these lipid shells, there would be no mRNA vaccines for COVID-19.

Continue reading “Without these lipid shells, there would be no mRNA vaccines for COVID-19” »

A team of researchers from Verve Therapeutics and the Perelman School of Medicine at the University of Pennsylvania has developed a CRISPR gene-editing technique that lowered the levels of cholesterol in the blood of test monkeys. In their paper published in the journal Nature, the researchers describe their technique.

Prior research has shown that in some people, the PCSK9 gene codes excess PCSK9 protein production (which occurs mostly in the liver)—leading to an increase in lipoprotein cholesterol levels in the bloodstream. This is because it interferes with blood cells with LDL receptors that “grab” LDL and remove it. For this reason, pharmaceutical companies have developed therapies that reduce the production of PCSK9 protein. However, most do not work well enough, which is why there is still so much atherosclerotic cardiovascular disease. In this new effort, the researchers have tried another approach—altering the PCSK9 gene to make it stop coding for PCSK9 protein production.

The approach involved using a base editing technology made up of messenger RNA encoding for an adenine base editor along with guided RNA that was packaged in a lipid nanoparticle. Notably, the base editing technique was able to substitute a single nucleotide with another in the DNA without cutting the double helix. Prior research has shown the technique to be more precise, which means fewer errors than other CRISPR techniques. In their work, the researchers replaced an adenine with a guanine and a thymine with a cytosine, completely incapacitating the gene. Implementation of the therapy involved a one-time injection into the liver of cynomolgus monkeys.

Origin of Information —“Something Very Old, Very Powerful and Very Special has Been Unleashed on Earth” | The Daily Galaxy.

“Humans are strange…We are the aliens,” observes Columbia University astrophysicist, Caleb Scharf, noting that humans are a striking anomaly in the natural world. “We also have a truly outsize impact on the planetary environment without much in the way of natural attrition to trim our influence (at least not yet).

Continue reading “Origin of Information --‘Something Very Old, Very Powerful and Very Special has Been Unleashed on Earth’” »

New battery cells developed by Australia’s Graphene Manufacturing Group and the University of Queensland are said to charge up to 70 times faster than lithium-ion cells and have triple the battery life.

Atomically thin materials are a promising alternative to silicon-based transistors; now researchers can connect them more efficiently to other chip elements.

Moore’s Law, the famous prediction that the number of transistors that can be packed onto a microchip will double every couple of years, has been bumping into basic physical limits. These limits could bring decades of progress to a halt, unless new approaches are found.

One new direction being explored is the use of atomically thin materials instead of silicon as the basis for new transistors, but connecting those “2D” materials to other conventional electronic components has proved difficult.